Atea Pharmaceuticals Files 8-K on Financials
Ticker: AVIR · Form: 8-K · Filed: Mar 6, 2025 · CIK: 1593899
| Field | Detail |
|---|---|
| Company | Atea Pharmaceuticals, Inc. (AVIR) |
| Form Type | 8-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
Atea Pharma filed an 8-K on March 6th for financial updates, but no numbers yet.
AI Summary
Atea Pharmaceuticals, Inc. filed an 8-K on March 6, 2025, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational details beyond its classification as a current report.
Why It Matters
This filing indicates Atea Pharmaceuticals is providing updates on its financial status and operational results to the SEC, which is standard for public companies but lacks specific details in this initial report.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K for financial and operational updates, with no immediate negative or positive news disclosed.
Key Players & Entities
- Atea Pharmaceuticals, Inc. (company) — Registrant
- March 6, 2025 (date) — Date of earliest event reported
FAQ
What specific financial results or operational updates are being reported by Atea Pharmaceuticals in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but specific figures or details are not provided in the provided text.
What is the filing date for this 8-K report?
The report was filed on March 6, 2025.
What is the principal executive office address for Atea Pharmaceuticals?
The principal executive offices are located at 225 Franklin Street, Suite 2100, Boston, MA 02110.
What is the SIC code for Atea Pharmaceuticals?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for Atea Pharmaceuticals?
The SEC file number is 001-39661.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding Atea Pharmaceuticals, Inc. (AVIR).